Abstract
People carrying germline mutations in mismatch repair genes are at high risk of colorectal cancer (CRC), yet about half of people from mutation-carrying families decline genetic counselling and/or testing to identify mutation status. We studied the association of quantitative measures of risk perception, risk prediction and self-reported screening colonoscopy in this elusive yet high-risk group. The sample of 26 participants (mean age 43.1 years, 14 women) in the Australasian Colorectal Cancer Family Registry were relatives of mutation carriers; had not been diagnosed with any cancer at the time of recruitment and had declined an invitation to attend genetic counselling and/or testing. A structured elicitation protocol captured perceived CRC risk over the next 10 years. Self-reported colonoscopy screening was elicited during a 45-minute semi-structured interview. Predicted 10-year CRC risk based on age, gender, known mutation status and family history was calculated using “MMRpro.” Mean perceived 10-year risk of CRC was 31 % [95 % CI 21, 40], compared with mean predicted risk of 4 % [2, 7] (p < 0.001); this was independent of age and sex (p = 0.9). Among those reporting any medical advice and any screening colonoscopy (n = 18), those with higher risk perception had less frequent colonoscopy (Pearson’s r = 0.49 [0.02, 0.79]). People who decline genetic testing for CRC susceptibility mutations perceive themselves to be at substantially higher risk than they really are. Those with high perceived risk do not undertake screening colonoscopy more often than those who perceive themselves to be at average risk.
Similar content being viewed by others
References
Ancker, J. S., Weber, E. U., & Kukafka, R. (2011). Effects of game-like interactive graphics on risk perceptions and decisions. Medical Decision Making, 31, 130–142.
Armelao, F., Orlandi, P. G., Tasini, E., Franceschini, G., Franch, R., Paternolli, C., et al. (2010). High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study. Endoscopy, 42, 15–21.
Ashida, S., Hadley, D. W., Goergen, A. F., Skapinsky, K. F., Devlin, H. C., & Koehly, L. M. (2011). The importance of older family members in providing social resources and promoting cancer screening in families with a hereditary cancer syndrome. Gerontologist, 51, 833–842.
Baglietto, L., Lindor, N. M., Dowty, J. G., White, D. M., Wagner, A., Gomez Garcia, E. B., et al. (2010). Risks of Lynch syndrome cancers for MSH6 mutation carriers. JNCI, 102, 193–201.
Brewer, N. T., Weinstein, N. D., Cuite, C. L., & Herrington, J. E. (2004). Risk perceptions and their relation to risk behavior. Annals of Behavioral Medicine, 27, 125–130.
Bonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Huiart, L., Longy, M., Guimbaud, R., et al. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA: The Journal of the American Medical Association, 305, 2304–2310.
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., et al. (2006). Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA: The Journal of the American Medical Association, 296, 1479–1487.
Claes, E., Denayer, L., Evers-Kiebooms, G., Boogaerts, A., Philippe, K., Tejpar, S., et al. (2005). Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Testing, 9, 54–65.
Codori, A. M., Petersen, G. M., Miglioretti, D. L., & Boyd, P. (2001). Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Preventive Medicine, 33, 128–136.
Cole, S. R., Smith, A., Wilson, C., Turnbull, D., Esterman, A., & Young, G. P. (2007). An advance notification letter increases participation in colorectal cancer screening. Journal of Medical Screening, 14, 73–75.
Collins, V., Meiser, B., Gaff, C., St John, D. J., & Halliday, J. (2005). Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer, 104, 273–281.
Collins, V. R., Meiser, B., Ukoumunne, O. C., Gaff, C., St John, D. J., & Halliday, J. L. (2007). The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genetics in Medicine, 9, 290–297.
de Jong, A. E., Hendriks, Y. M., Kleibeuker, J. H., de Boer, S. Y., Cats, A., Griffioen, G., et al. (2006). Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology, 130, 665–671.
Domanska, K., Carlsson, C., Bendahl, P.-O., & Nilbert, M. (2009). Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels. BMC Medical Genetics, 10, 30.
Flander, L., Dixon, W., McBride, M., & Burgman, M. (2012). Facilitated expert judgment of environmental risks: acquiring and analysing imprecise data. IJRAM, 16, 199–212.
Fletcher, R. H., Lobb, R., Bauer, M. R., Kemp, J. A., Palmer, R. C., Kleinman, K. P., et al. (2007). Screening patients with a family history of colorectal cancer. Journal of General Internal Medicine, 22, 508–513.
Gimeno Garcia, A. Z., Quintero, E., Nicolas Perez, D., Hernandez, M., & Jimenez, S. A. (2011). Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening. European Journal of Gastroenterology and Hepatology, 23, 1165–1171.
Glenn, B. A., Herrmann, A. K., Crespi, C. M., Mojica, C. M., Chang, L. C., Maxwell, A. E., et al. (2011). Changes in risk perceptions in relation to self-reported colorectal cancer screening among first-degree relatives of colorectal cancer cases enrolled in a randomized trial. Health Psychology, 30, 481–491.
Hadley, D. W., Jenkins, J. F., Dimond, E., de Carvalho, M., Kirsch, I., & Palmer, C. G. (2004). Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology, 22, 39–44.
Harris, M. A., & Byles, J. E. (1997). A survey of screening compliance among first degree relatives of people with colon cancer in New South Wales. Journal of Medical Screening, 4, 29–34.
Harris, M. A., Treloar, C. J., & Byles, J. E. (1998). Colorectal cancer screening: discussions with first degree relatives. Aust NZ J Pub Health, 22, 826–828.
Jarvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomaki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118, 29–34.
Kahneman, D., Slovic, P., & Tversky, A. (1982). Judgement under uncertainty: Heuristics and biases. Cambridge: Cambridge University Press.
Katapodi, M. C., Lee, K. A., Facione, N. C., & Dodd, M. J. (2004). Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Preventive Medicine, 38, 388–402.
Keogh, L. A., van Vliet, C. M., Studdert, D. M., Maskiell, J. A., Macrae, F. A., St John, D. J., et al. (2009). Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? The Medical Journal of Australia, 191, 255–258.
Longacre, A. V., Cramer, L. D., & Gross, C. P. (2006). Screening colonoscopy use among individuals at higher colorectal cancer risk. Journal of Clinical Gastroenterology, 40, 490–496.
Lynch, H. T., & de la Chapelle, A. (2003). Hereditary colorectal cancer. NEJM, 348, 919–932.
Mack, L. A., Cook, L. S., Temple, W. J., Carlson, L. E., Hilsden, R. J., & Paolucci, E. O. (2009). Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Annals Surg Oncol, 16, 2092–2100.
Madlensky, L., Esplen, M. J., Gallinger, S., McLaughlin, J. R., & Goel, V. (2003). Relatives of colorectal cancer patients: factors associated with screening behavior. American Journal of Preventive Medicine, 25, 187–194.
Madlensky, L., Daftary, D., Burnett, T., Harmon, P., Jenkins, M., Maskiell, J., et al. (2007). Accuracy of colorectal polyp self-reports: findings form the colon cancer family registry. Cancer Epidemiol Biomarkers Prevent, 16, 1898–1901.
Manne, S., Markowitz, A., Winawer, S., Meropol, N. J., Haller, D., Rakowski, W., et al. (2002). Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychology, 21, 3–15.
McCann, S., MacAuley, D., Barnett, Y., Bunting, B., Bradley, A., Jeffers, L., et al. (2009). Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psycho-oncol, 18, 1208–1215.
McKenzie, C., Liersch, M., & Yaniv, I. (2008). Overconfidence in interval estimates: what does expertise buy you? Organ Behav Hum Dec, 107, 179–191.
National Health and Medical Research Council: NHMRC. (2005) Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Accessed December 6, 2011, from http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp106_0.pdf
Newcomb, P. A., Baron, J., Cotterchio, M., Gallinger, S., Grove, J., Haile, R., et al. (2007). The colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prevent, 16, 2331–2343.
Palmer, R. C., Emmons, K. M., Fletcher, R. H., Lobb, R., Miroshnik, I., Kemp, J. A., et al. (2007). Familial risk and colorectal cancer screening health beliefs and attitudes in an insured population. Preventive Medicine, 45, 336–341.
R Development Core Team (2008). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
Santos, E. M., Lourenco, M. T., & Rossi, B. M. (2011). Risk perception among Brazilian individuals with high risk for colorectal cancer and colonoscopy. Hereditary Cancer in Clinical Practice, 9, 4.
Schapira, M. M., Nattinger, A. B., & McHorney, C. A. (2001). Frequency or probability? A qualitative study of risk communication formats used in health care. Medical Decision Making, 21, 459–467.
Schmeler, K. M., Lynch, H. T., Chen, L. M., Munsell, M. S., Soliman, P. T., Clark, M. B., et al. (2006). Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. NEJM, 354, 261–269.
Schwarzer, R., Luszczynska, A., Ziegelmann, J. P., Scholz, U., & Lippke, S. (2008). Social-cognitive predictors of physical exercise adherence: three longitudinal studies in rehabilitation. Health Psychology, 27, S54–S63.
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., et al. (2008). The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology, 135, 419–428.
Shiloh, S., & Ilan, S. (2005). To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing. Journal of Behavioral Medicine, 28, 467–479.
Soll, J. B., & Klayman, J. (2004). Overconfidence in interval estimates. Journal of Experimental Psychology: Learning, Memory, and Cognition, 30, 299–314.
Speirs-Bridge, A., Fidler, F., McBride, M., Flander, L., Cumming, G., & Burgman, M. (2010). Reducing overconfidence in the interval judgments of experts. Risk Analysis, 30, 512–523.
Taouqi, M., Ingrand, I., Beauchant, M., Migeot, V., & Ingrand, P. (2010). Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France. BMC Cancer, 10, 355.
Visschers, V. H., Meertens, R. M., Passchier, W. W., & de Vries, N. N. (2009). Probability information in risk communication: a review of the research literature. Risk Analysis, 29, 267–287.
Win, A. K., Dowty, J. G., English, D. R., Campbell, P. T., Young, J. P., Winship, I., et al. (2011). Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Brit J Cancer, 105, 162–169.
Win, A. K., Young, J. P., Lindor, N., Tucker, K. M., Ahnen, D. J., Young, G. P., et al. (2012). Colorectal and other cancer risks for carriers and non-carriers of a DNA mismatch repair gene mutation from mutation carrying families: a prospective cohort study. Journal of Clinical Oncology, 30, 958–964.
Wong, C., Gibbs, P., Johns, J., Jones, I., Faragher, I., Lynch, E., et al. (2007). Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing? Internal Medicine Journal, 38, 328–333.
Disclosure of Interest
This work was supported by the Victorian Cancer Agency under #EO109-33, National Cancer Institute, National Institutes of Health under RFA #CA-95-011, and through cooperative agreements with the Australasian Colorectal Cancer Family Registry (U01 CA097735). Mark Jenkins is supported as a Senior Research Fellow by the National Health & Medical Research Council, Australia. Driss Ait Ouakrim was supported by an Australian Commonwealth Scientific and Industrial Research Organisation PhD scholarship (CSIRO, Preventative Heath Flagship). Aung Ko Win is supported by a grant from the Cancer Council Victoria and the Picchi Brothers Foundation, Australia. Authors have full control of all primary data and agree to review if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Flander, L., Speirs-Bridge, A., Rutstein, A. et al. Perceived Versus Predicted Risks of Colorectal Cancer and Self-Reported Colonoscopies by Members of Mismatch Repair Gene Mutation-Carrying Families Who Have Declined Genetic Testing. J Genet Counsel 23, 79–88 (2014). https://doi.org/10.1007/s10897-013-9614-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-013-9614-2